These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32998512)
1. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19. Pantelis C; Jayaram M; Hannan AJ; Wesselingh R; Nithianantharajah J; Wannan CM; Syeda WT; Choy KC; Zantomio D; Christopoulos A; Velakoulis D; O'Brien TJ Aust N Z J Psychiatry; 2021 Aug; 55(8):750-762. PubMed ID: 32998512 [TBL] [Abstract][Full Text] [Related]
2. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic. Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076 [TBL] [Abstract][Full Text] [Related]
3. Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications. Vashisht A; Vashisht V; Singh H; Ahluwalia P; Mondal AK; Williams C; Farmaha J; Woodall J; Kolhe R Viruses; 2024 Jul; 16(8):. PubMed ID: 39205157 [TBL] [Abstract][Full Text] [Related]
4. Neurological Sequelae of COVID-19. Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158 [TBL] [Abstract][Full Text] [Related]
6. The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. de Sousa Moreira JL; Barbosa SMB; Vieira JG; Chaves NCB; Felix EBG; Feitosa PWG; da Cruz IS; da Silva CGL; Neto MLR Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110159. PubMed ID: 33147504 [TBL] [Abstract][Full Text] [Related]
7. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001 [TBL] [Abstract][Full Text] [Related]
8. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Yachou Y; El Idrissi A; Belapasov V; Ait Benali S Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449 [TBL] [Abstract][Full Text] [Related]
9. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508 [TBL] [Abstract][Full Text] [Related]
11. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D; J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661 [TBL] [Abstract][Full Text] [Related]
12. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19. Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants. Figueiredo CP; Fontes-Dantas FL; da Poian AT; Clarke JR Neuropharmacology; 2021 Dec; 201():108841. PubMed ID: 34666076 [TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765 [TBL] [Abstract][Full Text] [Related]
15. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus]. Bereczki D; Stang R; Böjti P; Kovács T Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306 [TBL] [Abstract][Full Text] [Related]
16. Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy. Kumar H; Gupta R Int J Neurosci; 2024 Apr; 134(4):323-332. PubMed ID: 35815479 [TBL] [Abstract][Full Text] [Related]
17. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 and its effects on neurological functions. Yew MMT; Lip JQ; Ling APK Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117 [TBL] [Abstract][Full Text] [Related]
19. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated? Principi N; Esposito S Ital J Pediatr; 2021 Sep; 47(1):191. PubMed ID: 34537061 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Amruta N; Chastain WH; Paz M; Solch RJ; Murray-Brown IC; Befeler JB; Gressett TE; Longo MT; Engler-Chiurazzi EB; Bix G Cytokine Growth Factor Rev; 2021 Apr; 58():1-15. PubMed ID: 33674185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]